Annual Cash & Cash Equivalents
$47.32 M
-$36.94 M-43.84%
31 December 2023
Summary:
Century Therapeutics annual cash & cash equivalents is currently $47.32 million, with the most recent change of -$36.94 million (-43.84%) on 31 December 2023. During the last 3 years, it has risen by +$20.11 million (+73.91%). IPSC annual cash & cash equivalents is now -43.84% below its all-time high of $84.27 million, reached on 31 December 2022.IPSC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$52.59 M
+$11.14 M+26.86%
30 September 2024
Summary:
Century Therapeutics quarterly cash and cash equivalents is currently $52.59 million, with the most recent change of +$11.14 million (+26.86%) on 30 September 2024. Over the past year, it has dropped by -$2.71 million (-4.91%). IPSC quarterly cash and cash equivalents is now -80.68% below its all-time high of $272.28 million, reached on 30 June 2021.IPSC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.8% | -4.9% |
| 3 y3 years | +73.9% | -48.1% |
| 5 y5 years | - | - |
IPSC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.8% | +73.9% | -58.3% | +26.9% |
| 5 y | 5 years | -43.8% | +73.9% | -80.7% | +93.3% |
| alltime | all time | -43.8% | +73.9% | -80.7% | +93.3% |
Century Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $52.59 M(+26.9%) |
| June 2024 | - | $41.46 M(-11.4%) |
| Mar 2024 | - | $46.81 M(-1.1%) |
| Dec 2023 | $47.32 M(-43.8%) | $47.32 M(-14.4%) |
| Sept 2023 | - | $55.31 M(-14.2%) |
| June 2023 | - | $64.44 M(-25.8%) |
| Mar 2023 | - | $86.83 M(+3.0%) |
| Dec 2022 | $84.27 M | $84.27 M(-24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $111.35 M(-1.3%) |
| June 2022 | - | $112.79 M(-10.5%) |
| Mar 2022 | - | $126.04 M(+123.3%) |
| Dec 2021 | $56.45 M(+107.4%) | $56.45 M(-44.3%) |
| Sept 2021 | - | $101.29 M(-62.8%) |
| June 2021 | - | $272.28 M(+242.6%) |
| Mar 2021 | - | $79.48 M(+192.1%) |
| Dec 2020 | $27.21 M(-38.2%) | $27.21 M |
| Dec 2019 | $44.06 M | - |
FAQ
- What is Century Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Century Therapeutics?
- What is Century Therapeutics annual cash & cash equivalents year-on-year change?
- What is Century Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Century Therapeutics?
- What is Century Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Century Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of IPSC is $47.32 M
What is the all time high annual cash & cash equivalents for Century Therapeutics?
Century Therapeutics all-time high annual cash & cash equivalents is $84.27 M
What is Century Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, IPSC annual cash & cash equivalents has changed by -$36.94 M (-43.84%)
What is Century Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IPSC is $52.59 M
What is the all time high quarterly cash and cash equivalents for Century Therapeutics?
Century Therapeutics all-time high quarterly cash and cash equivalents is $272.28 M
What is Century Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, IPSC quarterly cash and cash equivalents has changed by -$2.71 M (-4.91%)